Available Technologies

Browse Penn-owned technologies available for licensing.

Hypercholesterolemia and tendinous injuries

Technology Overview: 

This invention relates to a novel discovery on the use of cholesterol lowering agents to treat tendon injuries. Based on clinical and basic research, the Penn inventors have demonstrated that hyperlipidemia has deleterious effects on the overall structure and function of tendons rendering them more susceptible to injury and potentially interfering with the optimal healing process post-injury.

The University of Pennsylvania has an issued US Patent claiming this new use of cholesterol lowering agents, primarily statins, for use in patients with tendon injuries. This treatment would provide a new use indication for statins and a potentially powerful tool for the treatment of tendon injuries.

Intellectual Property: 

Issued US patent(s): 8,383,684 & 13,767,515

Reference Media: 

Abboud, J. A., et al., Clin Orthop Relat Res. 2012 Jan; 470(1):317-20

Patent Information:


Docket # U4627

For Information, Contact:

Jeffrey James Associate Director, PSOM Licensing Group
University of Pennsylvania